- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Lupus
The Rheumatology Network lupus clinical focus page provides information on the latest lupus news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for systemic lupus erythematosus drugs.
CAR T Cell Therapy Offers a New Hope in the Treatment of Severe and Refractory Systemic Lupus Erythematosus
October 03, 2022
The findings of this study of anti-CD19 directed CAR T cell therapy offers new hope for the most severe and refractory cases.
Lupus Treatment Considerations Post Immunosuppressants
September 29, 2022
Anne E. Winkler, MD, PhD, MACP shares her approach to treatment in patients with lupus post treatment with immunosuppressants with a focus on treatment sequencing.
Treatment Considerations in Lupus Nephritis
September 29, 2022
Drs Anne E. Winkler and Kristi V. Mizelle explore relevant treatment options for a patient with lupus nephritis and highlight efficacy and safety considerations.
Mycophenolic Acid Treatment Not Associated with More Severe COVID-19 Infection
September 28, 2022
Throughout the pandemic, rheumatologists have been concerned that their patients may be at risk of developing more severe forms of the COVID-19 disease as a result of their rheumatic disease or treatment.
How will Overturning Roe v Wade Affect Rheumatology?
September 23, 2022
Bonnie L Bermas, MD, discusses the ways in which the Supreme Court decision to overturn Roe v Wade will change the way rheumatologists are able to care for their patients.
Lupus Case Scenario: Treatment Approach
September 22, 2022
An expert in lupus management provides insight into her treatment approach for a 24-year-old African American female diagnosed with lupus nephritis.
Lupus Case Scenario: Patient History and Presentation
September 22, 2022
Lupus Case Scenario: Patient History and Presentation
Fatigue May Artificially Increase Disease Activity Scores in Lupus
September 21, 2022
Fatigue, a highly multifactorial manifestation of lupus, can be related to disease activity or independent of the disease itself. Investigators determined whether fatigue could be a significant confounder of Physician Global Assessment ratings.
Patients with Severe Lupus Achieve Remission with Anti-CD19 CAR T Cell Therapy
September 20, 2022
The highly encouraging results of the small study may lead to a new therapeutic approach in lupus. However, long-term safety and efficacy need to be evaluated in a larger cohort.
Treat to Target In Lupus Management
September 15, 2022
Anne E. Winkler, MD, PhD, MACP and Kristi V. Mizelle, MD, MPH, FACR hypothesize about the role and future of a treat to target approach in patients with lupus.